GPs are experiencing a substantial rise in their workload due to patient enquiries about the weight-loss injection Mounjaro, a new poll suggests.
The survey, involving over 1,200 GPs and practice nurses, reveals that one in 25 consultations now include discussions about the drug, either as the primary reason for the appointment or as an additional query.
